Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-30

Clinical Trial Update: FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing FOLFIRI and mFOLFOX6 as adjuvant chemotherapy for colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN